BiotechTube
Home/Hoth Therapeutics/Robb Knie
RK

Robb Knie

Chief Executive Officer

Hoth Therapeutics

Therapeutic Areas

DermatologyOncologyNeurologyInflammatory Diseases

Hoth Therapeutics Pipeline

DrugIndicationPhase
BioLexa PlatformAtopic Dermatitis (Eczema)Phase 2
Pipeline ProgramDermatological DisordersPre-clinical